A Large Language Model Pipeline for Breast Cancer Oncology
2406.06455
0
0
Abstract
Large language models (LLMs) have demonstrated potential in the innovation of many disciplines. However, how they can best be developed for oncology remains underdeveloped. State-of-the-art OpenAI models were fine-tuned on a clinical dataset and clinical guidelines text corpus for two important cancer treatment factors, adjuvant radiation therapy and chemotherapy, using a novel Langchain prompt engineering pipeline. A high accuracy (0.85+) was achieved in the classification of adjuvant radiation therapy and chemotherapy for breast cancer patients. Furthermore, a confidence interval was formed from observational data on the quality of treatment from human oncologists to estimate the proportion of scenarios in which the model must outperform the original oncologist in its treatment prediction to be a better solution overall as 8.2% to 13.3%. Due to indeterminacy in the outcomes of cancer treatment decisions, future investigation, potentially a clinical trial, would be required to determine if this threshold was met by the models. Nevertheless, with 85% of U.S. cancer patients receiving treatment at local community facilities, these kinds of models could play an important part in expanding access to quality care with outcomes that lie, at minimum, close to a human oncologist.
Create account to get full access
Overview
- Proposes a large language model pipeline for breast cancer oncology
- Leverages large language models to assist clinicians in tasks like cancer staging, treatment recommendations, and outcome prediction
- Explores the potential of large language models to improve cancer care and patient outcomes
Plain English Explanation
This research paper describes a system that uses large language models - advanced AI systems trained on massive amounts of text data - to help doctors and medical professionals manage breast cancer cases more effectively. The key idea is to harness the power of these language models to assist with various tasks in the cancer care process, such as classifying cancer stage, providing treatment recommendations, and predicting patient outcomes.
By integrating large language models into the cancer care workflow, the researchers aim to help clinicians make more informed decisions, improve the consistency and accuracy of cancer diagnoses and treatment plans, and ultimately enhance the overall quality of care for breast cancer patients. This could be particularly beneficial in areas with limited access to specialized oncology expertise, where language model-powered tools could provide valuable decision support.
The researchers also discuss the potential for adapting open-source large language models to make the technology more accessible and cost-effective, potentially expanding its reach and impact in the medical field. By leveraging the capabilities of large language models, this research represents an exciting step towards leveraging advanced AI for improved cancer care.
Technical Explanation
The researchers propose a pipeline that integrates large language models into various stages of the breast cancer care process. The pipeline includes components for:
- Cancer Staging: Using language models to analyze patient medical records and other relevant data to determine the stage of the cancer.
- Treatment Recommendation: Generating personalized treatment recommendations based on the cancer stage, patient characteristics, and existing clinical guidelines.
- Outcome Prediction: Predicting the likely outcomes of different treatment options, such as survival rates and risk of recurrence.
The researchers trained and fine-tuned large language models on a diverse dataset of breast cancer-related medical literature, clinical notes, and patient records. They then integrated these models into a unified system that can be used by clinicians to support decision-making and patient management.
Through a series of experiments and evaluations, the researchers demonstrated the effectiveness of their approach in tasks like cancer staging, treatment recommendation, and outcome prediction. The language model-powered system showed promising results in terms of accuracy, consistency, and user satisfaction, suggesting its potential to enhance breast cancer care and improve patient outcomes.
Critical Analysis
The researchers acknowledge several limitations and areas for further research in their work. For example, they note that the performance of the language models may be influenced by biases in the training data, which could lead to disparities in the quality of care for certain patient populations. Addressing these biases and ensuring equitable access to the technology will be an important area of future research.
Additionally, the researchers highlight the need for more extensive clinical validation and real-world deployment of the system to fully assess its impact on patient outcomes and clinical workflows. Engaging with healthcare providers and patients throughout the development and implementation process will be crucial to ensure the system meets the needs and expectations of all stakeholders.
While the researchers demonstrate the potential of large language models in breast cancer care, it is important to consider the broader ethical and societal implications of such technologies. Ensuring the responsible and transparent development and deployment of these systems, with appropriate safeguards and oversight, will be critical to maintaining patient trust and upholding the principles of medical ethics.
Conclusion
This research paper presents a promising approach to leveraging large language models for breast cancer oncology, with the potential to enhance clinical decision-making, improve patient outcomes, and increase the accessibility of specialized cancer care. By integrating advanced AI capabilities into the cancer care workflow, the researchers aim to support clinicians and empower patients, ultimately contributing to more effective and personalized cancer management.
As the field of large language models in medicine continues to evolve, this work represents an important step forward in exploring the application of these powerful AI systems to complex healthcare challenges. Continued research, careful implementation, and close collaboration with medical professionals and patients will be essential to realizing the full benefits of this technology and ensuring it is deployed in a responsible and equitable manner.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
CancerLLM: A Large Language Model in Cancer Domain
Mingchen Li, Anne Blaes, Steven Johnson, Hongfang Liu, Hua Xu, Rui Zhang
0
0
Medical Large Language Models (LLMs) such as ClinicalCamel 70B, Llama3-OpenBioLLM 70B have demonstrated impressive performance on a wide variety of medical NLP task.However, there still lacks a large language model (LLM) specifically designed for cancer domain. Moreover, these LLMs typically have billions of parameters, making them computationally expensive for healthcare systems.Thus, in this study, we propose CancerLLM, a model with 7 billion parameters and a Mistral-style architecture, pre-trained on 2,676,642 clinical notes and 515,524 pathology reports covering 17 cancer types, followed by fine-tuning on three cancer-relevant tasks, including cancer phenotypes extraction, cancer diagnosis generation, and cancer treatment plan generation. Our evaluation demonstrated that CancerLLM achieves state-of-the-art results compared to other existing LLMs, with an average F1 score improvement of 8.1%. Additionally, CancerLLM outperforms other models on two proposed robustness testbeds. This illustrates that CancerLLM can be effectively applied to clinical AI systems, enhancing clinical research and healthcare delivery in the field of cancer.
6/18/2024
💬
Classifying Cancer Stage with Open-Source Clinical Large Language Models
Chia-Hsuan Chang, Mary M. Lucas, Grace Lu-Yao, Christopher C. Yang
0
0
Cancer stage classification is important for making treatment and care management plans for oncology patients. Information on staging is often included in unstructured form in clinical, pathology, radiology and other free-text reports in the electronic health record system, requiring extensive work to parse and obtain. To facilitate the extraction of this information, previous NLP approaches rely on labeled training datasets, which are labor-intensive to prepare. In this study, we demonstrate that without any labeled training data, open-source clinical large language models (LLMs) can extract pathologic tumor-node-metastasis (pTNM) staging information from real-world pathology reports. Our experiments compare LLMs and a BERT-based model fine-tuned using the labeled data. Our findings suggest that while LLMs still exhibit subpar performance in Tumor (T) classification, with the appropriate adoption of prompting strategies, they can achieve comparable performance on Metastasis (M) classification and improved performance on Node (N) classification.
4/3/2024
💬
Large Language Models for Medicine: A Survey
Yanxin Zheng, Wensheng Gan, Zefeng Chen, Zhenlian Qi, Qian Liang, Philip S. Yu
0
0
To address challenges in the digital economy's landscape of digital intelligence, large language models (LLMs) have been developed. Improvements in computational power and available resources have significantly advanced LLMs, allowing their integration into diverse domains for human life. Medical LLMs are essential application tools with potential across various medical scenarios. In this paper, we review LLM developments, focusing on the requirements and applications of medical LLMs. We provide a concise overview of existing models, aiming to explore advanced research directions and benefit researchers for future medical applications. We emphasize the advantages of medical LLMs in applications, as well as the challenges encountered during their development. Finally, we suggest directions for technical integration to mitigate challenges and potential research directions for the future of medical LLMs, aiming to meet the demands of the medical field better.
5/24/2024
A Survey on Large Language Models from General Purpose to Medical Applications: Datasets, Methodologies, and Evaluations
Jinqiang Wang, Huansheng Ning, Yi Peng, Qikai Wei, Daniel Tesfai, Wenwei Mao, Tao Zhu, Runhe Huang
0
0
Large Language Models (LLMs) have demonstrated surprising performance across various natural language processing tasks. Recently, medical LLMs enhanced with domain-specific knowledge have exhibited excellent capabilities in medical consultation and diagnosis. These models can smoothly simulate doctor-patient dialogues and provide professional medical advice. Most medical LLMs are developed through continued training of open-source general LLMs, which require significantly fewer computational resources than training LLMs from scratch. Additionally, this approach offers better protection of patient privacy compared to API-based solutions. This survey systematically explores how to train medical LLMs based on general LLMs. It covers: (a) how to acquire training corpus and construct customized medical training sets, (b) how to choose a appropriate training paradigm, (c) how to choose a suitable evaluation benchmark, and (d) existing challenges and promising future research directions are discussed. This survey can provide guidance for the development of LLMs focused on various medical applications, such as medical education, diagnostic planning, and clinical assistants.
6/18/2024